Decision Diagnostics Corp
OTC:DECN

Watchlist Manager
Decision Diagnostics Corp Logo
Decision Diagnostics Corp
OTC:DECN
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: $354.5

Decision Diagnostics Corp
Investor Relations

Decision Diagnostics Corp. engages in prescription and non-prescription diagnostics and home testing products. The company is headquartered in Westlake Village, California. The company went IPO on 2002-02-08. The firm through its subsidiary, PharmaTech Solutions, Inc.,provides blood glucose home testing test strips. Its blood glucose home testing devices include GenUltimate and PetSure test strips, and GenUltimate 4Pets monitoring system. Its technology includes MD@Hand, which is a wireless, personal digital assistant in the form of a smartphone app that can be downloaded and used by physicians to access and update their patient’s histories, medication data, and care guidelines. The company develops cell phone centric, e-health products and technology. Practice Probe is the data mining utility meant to complement the digital assistant, MD@Hand. Additionally, it offers ResidenceWare, a collection of Internet-enhanced communication, integration, and networking tools developed for the real estate marketplace.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Keith M. Berman
CEO, CFO, Secretary & Director
No Bio Available
Mr. Mark Krakauer
Head of Genstrip Private Label Sales Efforts
No Bio Available

Contacts

Address
CALIFORNIA
Westlake Village
2660 Townsgate Rd Ste 300
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett